Drug Dosing and Pharmacokinetics in Children With Obesity
Margreet W. Harskamp–van Ginkel(Public Health Service of Amsterdam), Kevin Watt(University of Utah), Michael Cohen‐Wolkowiez(Duke University), Kevin D. Hill(Duke University), Daniela Testoni(Universidade Federal de São Paulo), Daniel González(University of North Carolina at Chapel Hill), Daniel K. Benjamin(Duke University), David Siegel(University of California, San Francisco), Patricia Banks(Duke University), Kristian C. Becker, Jeffrey S. Barrett(Aridhia (United Kingdom))
Cited by 103
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
|Obesity|2021|199
Gestational Age at Birth and Outcomes After Neonatal Cardiac Surgery
|Circulation|2014|197